U.S. Healthcare Services Stock News

StoneCo stock performance snapshot StoneCo (NasdaqGS:STNE) has been drawing attention after a mixed stretch for the stock, with the price near $11.33 and returns down over the past month and past 3 months but positive over the past year. See our latest analysis for StoneCo. The share price has been under pressure in recent months, with a 90 day share price return down 32.56% and the year to date share price return down 22.87%. At the same time, the 1 year total shareholder return is positive...

MINISO Group Holding (MNSO) is back in focus after reporting first quarter 2026 earnings, with revenue and net income figures that outpaced both internal guidance and analyst expectations, despite pressure on gross margins. See our latest analysis for MINISO Group Holding. Despite the upbeat first quarter report, MINISO Group Holding's recent share price performance has been weak, with the stock down 30.24% on a 90 day share price return and the 1 year total shareholder return falling 25.72%...

Lennar (NYSE:LEN) is partnering with technology providers to streamline building operations and manage costs in response to housing affordability pressures. The company is focusing on digital tools and data driven systems as mortgage rates and affordability challenges continue to affect the housing market. Lennar is taking a cost and efficiency focused approach at a time when many buyers are feeling the strain from housing affordability and higher mortgage rates. The stock recently closed...

York Space Systems (NYSE:YSS) is acquiring solar technology company Solestial to bring more key components in house. The company has also agreed to acquire ALL.SPACE, a communications technology provider, to further build out its domestic supply chain. These transactions are aimed at increasing manufacturing self sufficiency and reducing reliance on foreign suppliers for critical space hardware. For anyone tracking the small satellite and space infrastructure sector, NYSE:YSS sits at the...

Wondering whether Check Point Software Technologies at around US$131 is starting to look like value, or if the stock still carries too much downside risk. The share price closed at US$131.33, with returns down 0.3% over the last week, 5.7% over the last month, 27.5% year to date, and 41.5% over the past year, which naturally raises questions about what the current valuation is telling you. Recent coverage has focused on how the stock's weaker recent returns have shifted attention toward what...

Weibo (NasdaqGS:WB) opened 2026 with Q1 revenue of US$421.3 million and basic EPS of US$0.15, alongside trailing 12 month EPS of US$1.58 on revenue of US$1.8 billion. Over the past year, revenue has ranged from US$396.9 million in Q1 2025 to US$473.3 million in Q4 2025, while quarterly EPS has moved between a loss of US$0.02 in Q4 2025 and US$0.93 in Q3 2025. This sets the backdrop for a net profit margin of 21.1% over the last 12 months and frames this latest update as a story about how...

If you are wondering whether Black Hills at around US$73.09 is still reasonably priced or starting to look stretched, the next sections will walk through what the current market price might be implying. The stock has eased back over the past week and month, with returns of 1.4% and 2.9% respectively, but is still up 4.9% year to date and 30.9% over the last year. This sets a different context to the longer term 37.9% three year and 31.7% five year figures. Recent attention on Black Hills has...

Neogen (NEOG) shares came under pressure after the company reported quarterly earnings and revenue that exceeded analyst estimates, but revenue declined 4.4% year on year and trailed peers on growth. See our latest analysis for Neogen. At a share price of $9.30, Neogen has a 1-day share price return of 1.09% and a 7-day share price return of 4.97%. The 90-day share price return is down 17.19%, while the 1-year total shareholder return of 49.76% contrasts with a 3-year total shareholder return...

Wondering if PDD Holdings at around US$83.03 is starting to look like a bargain, or if the recent volatility is a warning sign for value focused investors? The stock is down 15.1% over the past week, 14.7% over the past month, 28.3% year to date and 15.5% over the past year, even though the 3 year return sits at 20.2%. Recent coverage has focused on broader concerns around consumer spending in China and ongoing regulatory attention on large platform companies, which continues to shape...

Samsara (NYSE:IOT) has earned the No. 1 ranking on 23 separate Summer 2026 G2 Grid Reports for fleet technology solutions. The company led multiple categories, including fleet management, asset tracking, and maintenance, based on customer reviews and market presence. Samsara, trading at $31.57, sits at an interesting point for investors after mixed recent share performance. The stock is up 4.7% over the past week and 7.6% over the past 30 days, but is down 6.9% year to date and down 31.0%...

In late May 2026, The Cheesecake Factory reported a robust first quarter with revenue, margins, and earnings all topping analyst expectations while broader consumer demand for dining and services remained firm. At the same time, a sharp drop in oil prices reduced fuel and transport costs and may encourage more customer visits, potentially amplifying the operational benefits of the company’s recent performance. We’ll now examine how lower energy costs, alongside these stronger quarterly...

Investor focus turns to Denali Therapeutics after trial setback Denali Therapeutics (DNLI) is back in focus after a Phase 2b study failed, prompting investors to reassess the stock around its remaining neurodegenerative and lysosomal disease pipeline, as highlighted by Morgan Stanley. See our latest analysis for Denali Therapeutics. Despite the recent trial setback, Denali Therapeutics' 1 day share price return of 3.66% and 7 day share price return of 8.55% suggest short term buying interest...

Immunovant (IMVT) has been drawing attention after recent share price moves, with the stock up about 24% over the past month and about 21% over the past 3 months, prompting closer scrutiny from biotech investors. See our latest analysis for Immunovant. At the current share price of US$33.50, Immunovant’s recent 30 day share price return of 24.12% and year to date share price return of 29.29% sit alongside a 1 year total shareholder return of 124.98%. This indicates strong momentum over both...

Copa Holdings (NYSE:CPA) drew fresh attention after reporting a 20.5% year-over-year jump in fiscal Q1 2026 earnings per share, along with improved operating and net margins that have caught investors' interest. See our latest analysis for Copa Holdings. At a share price of $142.16, Copa Holdings has seen its 30 day share price return rise 24.08%, while the 1 year total shareholder return of 38.18% points to momentum that has been building rather than fading. If this earnings driven move has...

FinVolution Group stock triggered by valuation gap FinVolution Group (FINV) is on investor radars after trading at an indicated intrinsic discount of about 70%, with the stock last closing at US$5.19 and a market value near US$1.35b. See our latest analysis for FinVolution Group. Recent trading has been choppy, with the share price falling 5.6% over the last session but still up 8.6% over the week. The 1 year total shareholder return is down 37%, while the 3 year total shareholder return is...

FTAI Aviation (FTAI) is back in focus after Crossroads Capital LLC highlighted the stock, pointing to its shift toward a capital-light, higher-visibility model built around PMA parts and a vertically integrated engine platform. See our latest analysis for FTAI Aviation. FTAI Aviation's latest focus from Crossroads Capital and its upcoming redemption of Series C preferred shares sit against a backdrop of strong momentum, with the share price up 24.93% year to date and a very large 1 year total...

Kite Realty Group Trust (KRG) continues to draw attention after recent share price moves, with investors weighing its income profile as a real estate investment trust against its performance over the past year and past 3 months. See our latest analysis for Kite Realty Group Trust. The recent 1 month share price return of 5.12% and year to date share price return of 15.46% sit alongside a 1 year total shareholder return of 30.10%, suggesting momentum has been building over time. If KRG’s move...

PROCEPT BioRobotics recently reported two milestones in its WATER IV prostate cancer program: completing enrollment in the 280-patient randomized trial comparing Aquablation to radical prostatectomy and securing FDA IDE approval for a second randomized study against active surveillance in up to 333 patients. These long-term, randomized trials could help clarify how Aquablation stacks up against both surgery and watchful waiting on cancer control and quality-of-life outcomes over a ten-year...

Pony AI Inc. has reported its first-quarter 2026 results, with revenue rising to US$34.25 million from US$13.98 million a year earlier, while net loss widened to US$50.41 million from US$42.99 million. Alongside this rapid top-line expansion, the company raised its 2026 robotaxi fleet and revenue targets as it scales operations across more cities and international markets. We’ll now look at how Pony AI’s raised robotaxi fleet target shapes the company’s investment narrative and future growth...

Recently, JFrog Ltd. (FROG) recorded a golden cross, with its 50-day moving average moving above its 200-day moving average while analysts raised earnings estimates, reinforcing attention on the company’s technical and fundamental setup. This combination of a widely watched technical signal and improving earnings expectations offers a rare alignment of chart-based and estimate-driven optimism for JFrog. We’ll now explore how this golden cross, together with stronger earnings estimates, might...

This article explores whether Nu Holdings is attractively priced or starting to look stretched, by examining what the current share price might be implying about the stock's underlying value. After closing at US$13.05, the stock is down 0.8% over the past week and down 10.0% over the past month. Over the past year the return is 8.8%, and the 3 year return is 91.1%. Recent coverage has focused on Nu Holdings as a fast growing digital bank in Latin America, which helps explain why investors...

STERIS (STE) shares have faced pressure recently, with the stock down about 2% over the past month and about 15% over the past 3 months, drawing attention to its current valuation. See our latest analysis for STERIS. Zooming out, the recent 3 month share price decline of about 14.6% and year to date share price decline of about 13.9% contrast with a 5 year total shareholder return of 18.6%. This suggests momentum has softened despite longer term gains. If you are comparing STERIS with other...

Ituran Location and Control (NasdaqGS:ITRN) has filed a universal shelf registration, allowing the company to issue a range of securities in the future. The filing enables potential offerings of ordinary shares, debt securities, warrants, and rights, depending on future funding needs and market conditions. Ituran Location and Control operates in vehicle tracking and telematics, providing location based services and control systems. The new shelf registration adds an extra funding tool...

Earnings and Clinical Data Put Roivant in Focus Roivant Sciences (ROIV) has moved into the spotlight after reporting Phase 2b results for IMVT-1402 in difficult-to-treat rheumatoid arthritis, alongside recent fourth quarter earnings and a new shelf registration filing. See our latest analysis for Roivant Sciences. At a share price of US$29.88, Roivant has seen a 36.25% year to date share price return and a very large 1 year total shareholder return, suggesting momentum has built around the...